Correlation Between Unity Biotechnology and Champions Oncology
Can any of the company-specific risk be diversified away by investing in both Unity Biotechnology and Champions Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unity Biotechnology and Champions Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unity Biotechnology and Champions Oncology, you can compare the effects of market volatilities on Unity Biotechnology and Champions Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unity Biotechnology with a short position of Champions Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unity Biotechnology and Champions Oncology.
Diversification Opportunities for Unity Biotechnology and Champions Oncology
0.18 | Correlation Coefficient |
Average diversification
The 3 months correlation between Unity and Champions is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Unity Biotechnology and Champions Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Champions Oncology and Unity Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unity Biotechnology are associated (or correlated) with Champions Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Champions Oncology has no effect on the direction of Unity Biotechnology i.e., Unity Biotechnology and Champions Oncology go up and down completely randomly.
Pair Corralation between Unity Biotechnology and Champions Oncology
Considering the 90-day investment horizon Unity Biotechnology is expected to under-perform the Champions Oncology. But the stock apears to be less risky and, when comparing its historical volatility, Unity Biotechnology is 1.14 times less risky than Champions Oncology. The stock trades about -0.19 of its potential returns per unit of risk. The Champions Oncology is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest 398.00 in Champions Oncology on August 29, 2024 and sell it today you would earn a total of 35.00 from holding Champions Oncology or generate 8.79% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Unity Biotechnology vs. Champions Oncology
Performance |
| Timeline |
| Unity Biotechnology |
| Champions Oncology |
Unity Biotechnology and Champions Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Unity Biotechnology and Champions Oncology
The main advantage of trading using opposite Unity Biotechnology and Champions Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unity Biotechnology position performs unexpectedly, Champions Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Champions Oncology will offset losses from the drop in Champions Oncology's long position.| Unity Biotechnology vs. Exscientia Ltd ADR | Unity Biotechnology vs. Recursion Pharmaceuticals | Unity Biotechnology vs. Atea Pharmaceuticals | Unity Biotechnology vs. Hookipa Pharma |
| Champions Oncology vs. Bright Minds Biosciences | Champions Oncology vs. HP Inc | Champions Oncology vs. Intel | Champions Oncology vs. Chevron Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |